These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Elevation of immunoreactive CSF TRH in depressed patients. Banki CM; Bissette G; Arato M; Nemeroff CB Am J Psychiatry; 1988 Dec; 145(12):1526-31. PubMed ID: 3143269 [TBL] [Abstract][Full Text] [Related]
29. CSF corticotropin-releasing factor is not affected in panic disorder. Jolkkonen J; Lepola U; Bissette G; Nemeroff C; Riekkinen P Biol Psychiatry; 1993 Jan; 33(2):136-8. PubMed ID: 8439604 [No Abstract] [Full Text] [Related]
30. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596 [TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Garakani A; Martinez JM; Yehuda R; Gorman JM J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611 [TBL] [Abstract][Full Text] [Related]
32. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings. Roy A; Wolkowitz OM; Bissette G; Nemeroff CB Am J Psychiatry; 1994 Apr; 151(4):600-2. PubMed ID: 7511876 [TBL] [Abstract][Full Text] [Related]
33. No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by cortisol administration. Kellner M; Salzwedel C; Wortmann V; Urbanowicz T; Boelmans K; Yassouridis A; Stalla GK; Wiedemann K Psychiatry Res; 2013 Dec; 210(2):662-4. PubMed ID: 23896353 [TBL] [Abstract][Full Text] [Related]
34. Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test. Galard R; Catalán R; Castellanos JM; Gallart JM Biol Psychiatry; 2002 Mar; 51(6):463-8. PubMed ID: 11922880 [TBL] [Abstract][Full Text] [Related]
35. Plasma corticotropin-releasing factor in depressive disorders. Catalán R; Gallart JM; Castellanos JM; Galard R Biol Psychiatry; 1998 Jul; 44(1):15-20. PubMed ID: 9646879 [TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Nikisch G; Agren H; Eap CB; Czernik A; Baumann P; Mathé AA Int J Neuropsychopharmacol; 2005 Sep; 8(3):403-10. PubMed ID: 15784158 [TBL] [Abstract][Full Text] [Related]
37. Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism]. Heinz A; Jones DW; Bissette G; Hommer D; Ragan P; Knable M; Wellek S; Linnoila M; Weinberger DR Pharmacopsychiatry; 2002 Jul; 35(4):127-34. PubMed ID: 12163982 [TBL] [Abstract][Full Text] [Related]
39. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. Holsboer F; Von Bardeleben U; Gerken A; Stalla GK; Müller OA N Engl J Med; 1984 Oct; 311(17):1127. PubMed ID: 6090905 [No Abstract] [Full Text] [Related]
40. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia. Risch SC; Lewine RJ; Kalin NH; Jewart RD; Risby ED; Caudle JM; Stipetic M; Turner J; Eccard MB; Pollard WE Neuropsychopharmacology; 1992 Feb; 6(2):95-100. PubMed ID: 1319168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]